Study Summary
This trial will test whether a new assessment of neurosensory phenotyping can predict which patients with chronic pancreatitis will respond best to endoscopic therapy or surgery.
- Chronic Pain
- Chronic Pancreatitis
Treatment Effectiveness
Effectiveness Progress
Study Objectives
1 Primary · 16 Secondary · Reporting Duration: 3, 6, and 12 months
Trial Safety
Safety Progress
Trial Design
1 Treatment Group
Pancreatic Quantitative Sensory Testing (P-QST)
1 of 1
Experimental Treatment
150 Total Participants · 1 Treatment Group
Primary Treatment: Quantitative Sensory Test 1 · No Placebo Group · N/A
Trial Logistics
Trial Timeline
Who is running the clinical trial?
Eligibility Criteria
Age 18+ · All Participants · 3 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:Frequently Asked Questions
How many participants are currently enrolled in this research project?
"Indeed, the information provided on clinicaltrials.gov affirms that this medical investigation is currently recruiting patients. The trial was initially posted on April 1st 2022 and has been revised more recently on January 17th of the same year. A total of 150 volunteers need to be enrolled from two locations." - Anonymous Online Contributor
Are there any vacancies open to partake in this clinical investigation?
"According to the clinicaltrials.gov registry, this experiment is actively seeking potential subjects. The trial was initially created on April 1st 2022 with a recent update on January 17th 2021." - Anonymous Online Contributor